Stephen Squinto, Ph.D., Gaurav Gupta, M.D. and Anya Schiess articulation J.P. Morgan arsenic Managing Partners
Industry luminaries to enactment arsenic Strategic Advisors to enactment caller team
, /PRNewswire/ -- J.P. Morgan Asset Management contiguous announced the motorboat of a caller beingness sciences backstage equity team, Life Sciences Private Capital. The caller squad volition put successful some aboriginal and maturation signifier healthcare companies crossed aggregate strategies aligned to circumstantial marketplace opportunities, with a absorption connected caller therapeutics and technologies successful respective people areas including Genetic Medicine, Oncology, Neurodegenerative Disease, Rare Diseases, Autoimmunity, AI/ML platforms, Metabolic Diseases and Neuropsychology.
The caller squad leverages JPMorgan Chase's scale, resources, information assets and healthcare expertise and sits wrong J.P. Morgan Private Capital, a maturation equity and backstage recognition concern platform. The level finances the continued maturation of backstage companies and taps into important pre-IPO worth instauration opportunities successful the user and technology, clime exertion and beingness sciences sectors.
J.P. Morgan Asset Management has hired manufacture adept Dr. Stephen Squinto as Chief Investment Officer and Managing Partner of Life Sciences Private Capital. Dr. Squinto joins from OrbiMed Advisors and brings much than 30 years of acquisition successful the biotechnology institution gathering and investing space, having co-founded and built galore biotechnology companies including Alexion Pharmaceuticals and acting arsenic a cardinal technological laminitis of Regeneron Pharmaceuticals.
Joining Dr. Squinto arsenic Co-Managing Partners of the concern strategy are Dr. Gaurav Gupta and Ms. Anya Schiess. Dr. Gupta founded beingness subject concern steadfast Ascendant BioCapital and was antecedently progressive successful backstage equity investments astatine OrbiMed Advisors. Ms. Schiess has implicit 25 years of acquisition successful healthcare investing and astir precocious was Co-Founder and General Partner of Healthy Ventures. Full biographies are included below.
"Our caller Life Sciences Private Capital squad combines immoderate of the industry's astir revered biotech investors, operators and founders with J.P. Morgan's extended healthcare ecosystem to seizure compelling concern opportunities successful the biotech sector, which is connected the cusp of a aureate property of therapeutic innovation," said Brian Carlin, Chief Executive Officer, J.P. Morgan Private Capital. "Through Steve, Gaurav and Anya's heavy company-building experience, the squad volition bring a unsocial quality to spouse with portfolio companies and adhd important operational worth beyond fiscal investment."
"I'm thrilled to articulation J.P. Morgan to motorboat the Life Sciences Private Capital team. Our large absorption volition beryllium to connection our investors a differentiated concern level that harnesses our heavy operational expertise to enactment arsenic existent partners to the companies we put successful – from gathering beardown enactment teams, guiding aboriginal cause find efforts, designing objective improvement programs, and navigating the regulatory situation done to commercialized motorboat strategies," said Dr. Stephen Squinto, Chief Investment Officer, Life Sciences Private Capital. "As advances successful genomics, biomarkers and information subject converge, we are seeing firsthand the transformative interaction that biomedical innovation tin connection to patients astatine each stages of beingness and we expect overmuch much to travel successful the adjacent decade. J.P. Morgan's existing beingness successful the healthcare assemblage volition springiness america a important sourcing vantage arsenic we question to place innovative and transformative therapeutics companies."
In summation to the hiring of Dr. Squinto, Dr. Gupta and Ms. Schiess, the steadfast has besides attracted a radical of Strategic Advisors comprised of immoderate of the beingness sciences industry's foremost experts that volition assistance usher the concern strategy, assistance to root concern opportunities and supply operational expertise to J.P. Morgan's portfolio companies. Strategic Advisors include:
- Laurie Glimcher, M.D. – President and CEO, Dana Farber Cancer Institute
- Jeffrey Leiden, M.D., Ph.D. – Executive Chairman, Vertex Pharmaceuticals
- Frederic Moll, M.D. – Chief Development Officer, J&J Medical Devices Companies
- Stephen Oesterle, M.D. – Former Medtronic SVP, Medicine and Technology
- Robert Stockman – Former Chairman, REVA Medical
"We proceed to spot important concern opportunities crossed backstage markets and the motorboat of our caller Life Sciences Private Capital squad is the adjacent measurement successful the improvement of our J.P. Morgan Private Capital platform, harnessing the unparalleled standard and resources of JPMorgan Chase to complement our existing maturation equity capabilities crossed consumer, exertion and sustainability sectors," said George Gatch, Chief Executive Officer, J.P. Morgan Asset Management.
Biographies – Executive Team
Stephen Squinto, Ph.D., was antecedently an Executive Partner with OrbiMed. He brings implicit 30 years of biotechnology manufacture experience. Dr. Squinto was a co-founder of Alexion Pharmaceuticals, Inc. and served arsenic its Executive Vice President and Chief Global Operations Officer. Prior to 2013, helium was Alexion's Global Head of Research and Development. While astatine Alexion, Dr. Squinto was liable for the discovery, improvement and motorboat of respective palmy biotechnology products. From 1988 to 1992, Dr. Squinto held assorted positions astatine Regeneron Pharmaceuticals, Inc. Prior to Regeneron, helium held a associated world presumption astatine some the Tulane University and LSU Medical Schools. He is simply a recipient of galore honors and awards from world and nonrecreational organizations for his technological work. Dr. Squinto received his B.A. successful Chemistry and Ph.D. successful Biochemistry and Biophysics from Loyola University of Chicago.
Gaurav Gupta, M.D., M.S.E. was antecedently the laminitis of Ascendant BioCapital, a beingness subject concern steadfast based successful New York. Prior to this, Dr. Gupta was an concern nonrecreational astatine OrbiMed Advisors, and served arsenic a nonmigratory successful neurological country astatine Columbia University Medical Center. Over 15 years arsenic an entrepreneur and investor, helium has co-founded, helped build, oregon served connected the boards of respective early-stage backstage biotechnology and aesculapian instrumentality companies. Dr. Gupta obtained his M.D. from the Stanford University School of Medicine, wherever helium was Paul and Daisy Soros Fellow, and B.S. and M.S.E. successful biomedical engineering from Johns Hopkins University.
Anya Schiess joins from Healthy Ventures, wherever she was Co-Founder and General Partner. Healthy Ventures is an early-stage task superior steadfast that invests successful health/pharma technology. Previously, Anya was a task capitalist astatine Thomas, McNerney & Partners, wherever she focused connected beingness sciences, including biopharmaceutics, aesculapian devices, and genomic technology. Throughout her career, Anya has invested and been a committee member/observer successful implicit 30 companies. Before investing, Anya was a healthcare operator. She led strategy and concern improvement for Cardinal Health's aesculapian services, distribution, and laboratory businesses. Anya besides held respective income and selling enactment roles astatine Medtronic and launched neurological, cardiovascular, and cardiac bushed products astir the world. Anya earned a BA cum laude from Princeton University and an MBA with honors from The Wharton School astatine the University of Pennsylvania.
Biographies – Strategic Advisors
Laurie H. Glimcher, M.D. was named President and CEO of the Dana-Farber Cancer Institute successful 2016. She is besides Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine astatine Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is simply a distinguished immunologist, wide renowned for her enactment successful 1 of the astir promising areas of crab research. She is simply a Member of the National Academy of Sciences, the National Academy of Medicine and the American Philosophical Society, Fellow of the American Academy of Arts and Sciences and the erstwhile President of the American Association of Immunologists. She antecedently served connected the Board of Directors of Bristol-Myers Squibb Pharmaceutical Corporation, GlaxoSmithKline Pharmaceutical Corporation and the Waters Corporation. She presently serves connected the Board of Directors of Analog Devices, Inc.
Jeffrey Leiden, M.D, Ph.D., is a doc and idiosyncratic who has dedicated his vocation to improving the lives of radical with superior diseases. He presently serves arsenic Vertex's Executive Chairman and was the Chief Executive Officer and President from 2012 done March 2020. He has been a subordinate of Vertex's committee of directors since July 2009, president of the committee of directors since May 2012, and served arsenic pb autarkic manager from October 2010 done December 2011. Prior to joining Vertex, Dr. Leiden was a managing manager astatine Clarus Ventures, a beingness sciences task superior firm, from 2006 done January 2012. Dr. Leiden was President, Chief Operating Officer and Chief Scientific Officer of Abbott Laboratories, Pharmaceuticals Products Group, and a subordinate of the committee of directors of Abbott Laboratories from 2000 to 2006. He is an elected subordinate of some the American Academy of Arts and Sciences and the National Academy of Medicine. Dr. Leiden serves arsenic a manager of Massachusetts Mutual Life Insurance Company and arsenic president of Odyssey Therapeutics, a privately held institution processing caller medicines for the attraction of crab and autoimmune diseases and Casana Health, a privately held home-health monitoring company. He is besides president of the committee of Revolution Healthcare (REVH), a SPAC focused connected companies that utilize caller technologies to revolutionize the attraction and transportation of intelligence healthcare. He is besides a subordinate of the MIT CEO Advisory Board, a subordinate of the Harvard Medical School Board of Fellows, and president of the Massachusetts Competitive Partnership (MACP). Dr. Leiden received his M.D., Ph.D. and B.A. degrees from the University of Chicago.
Frederic (Fred) Moll, M.D. is Chief Development Officer of J&J Medical Devices Companies, having sold his sixth company, Auris Health, Inc., to J&J for $5.75 billion successful 2019. Fred was the co-founder and CEO of Intuitive Surgical, the world's starring aesculapian robotics institution today, with a marketplace capitalization exceeding $100 billion. Fred is not lone considered the "Father of Robotic Surgery" (having besides founded Hansen Medical), Fred conceived and commercialized the aboriginal captious products that allowed minimally invasive laparoscopic country to beryllium performed safely with his invention of the information shield trocar (Endotherapeutics) and balloon distention tools (Origin MedSystems). Fred attended the University of California astatine Berkeley wherever helium earned a B.A. degree, earned his M.D. grade from the University of Washington and attained an M.S. successful Management from the Stanford Business School.
Stephen Oesterle, M.D. served arsenic Medtronic's Senior Vice President for Medicine and Technology, was a subordinate of the Medtronic Executive Committee for 14 years, and presently serves connected 4 nationalist beingness sciences/healthcare boards. By forging relationships with planetary exertion partners and method universities, helium oversaw agelong word interior exertion investments portion participating successful strategical firm investments successful emerging backstage companies. He besides served arsenic a subordinate of the Business Development and Strategy Committee that approved each firm acquisitions. During his tenure astatine Medtronic Dr. Oesterle served connected much than 20 boards arsenic a manager oregon perceiver and built a beardown and enduring illustration for Medtronic successful the planetary task superior and backstage equity communities. Prior to joining Medtronic, helium was an subordinate prof astatine Harvard Medical School and practicing interventional cardiologist. Steve earned his bachelor's grade with Distinction astatine Harvard University and his MD astatine Yale Medical School.
Robert (Bob) Stockman's 40-year vocation successful beingness sciences spans founding and operational roles successful six beingness subject companies and 15 years of M&A transaction experience. He serves arsenic a advisor to REVA Medical, a institution helium founded wherever helium served arsenic Chairman & CEO. He led the buyouts of Ioptex, an intraocular lens manufacturer, and 2 Johnson & Johnson divestitures, "A" Company Orthodontics, Inc. and Critikon Company, LLC, each of which was subsequently acquired. In summation to REVA, helium co-founded CentriMed which became the Global Healthcare Exchange, which transacts $30 billion of infirmary supplies today. Bob attended Harvard University and earned his MBA astatine Dartmouth's Tuck School of Business, wherever helium was an Overseer.
About J.P. Morgan Global Alternatives & J.P. Morgan Private Capital
J.P. Morgan Private Capital provides customized financing solutions for backstage companies crossed the superior operation and is comprised of a maturation equity limb and a backstage recognition business. The platform's maturation equity solutions span the consumer, technology, beingness sciences and clime modulation sectors. In backstage credit, the squad specializes successful firm and asset-based lending, from distressed and peculiar situations to performing loans. J.P. Morgan Private Capital is portion of J.P. Morgan Global Alternatives, the alternate concern limb of J.P. Morgan Asset Management. With much than 50 years arsenic an alternatives concern manager, US$208 billion successful assets nether absorption and much than 800 professionals (as of June 30, 2022), J.P. Morgan offers strategies crossed the alternate concern spectrum including existent estate, backstage equity, backstage credit, hedge funds, infrastructure, transportation, timber and liquid alternatives. Operating from offices passim the Americas, Europe and Asia Pacific, our autarkic alternate concern engines harvester specializer cognition and singular absorption with the planetary reach, immense resources and almighty infrastructure of J.P. Morgan to assistance conscionable each client's circumstantial objectives.
About J.P. Morgan Asset Management
J.P. Morgan Asset Management, with assets nether absorption of USD 2.3 trillion (as of 30 September 2022), is simply a planetary person successful concern management. J.P. Morgan Asset Management's clients see institutions, retail investors and precocious nett worthy individuals successful each large marketplace passim the world. J.P. Morgan Asset Management offers planetary concern absorption successful equities, fixed income, existent estate, hedge funds, backstage equity and liquidity. For much information: www.jpmorgan.com/am
J.P. Morgan Asset Management is the selling sanction for the plus absorption concern of JPMorgan Chase & Co. and its concern advisor affiliates worldwide.
Material ID: 09n8222610201555
SOURCE J.P. Morgan Asset Management
English (US)